Investing.com -- Barclays downgraded DexCom and Insulet, two large-cap diabetes device makers, to Underweight as it expects rising competition in 2026 and 2027 to weigh on valuation multiples and ...

ViCentra has raised $13m in the second close of its Series D funding round that will be directed towards advancing ...

In his inaugural J.P. Morgan Healthcare Conference speech, newly minted Dexcom CEO Jake Leach looked to ease concerns over ...

Food poisoning is never a fun experience. Sometimes, if you’re lucky, you’ll bite into something bad and realize soon enough ...

ConsentFix is an OAuth phishing technique abusing browser-based authorization flows to hijack Microsoft accounts. Push ...

The January 8, 2026 Patch for Overwatch 2 has arrived, bringing with it various game and event updates, Hero balance adjustments, and numerous ...

A significantly higher proportion of 4- to 7-year-olds with peanut allergy using the Viaskin Peanut patch were deemed ...

In July, Leach was tapped to take the CEO role permanently at the start of 2026 as part of Dexcom’s planned succession ...

Dark, velvety skin patches—known as acanthosis nigricans—can be an early warning sign of insulin resistance, prediabetes, or ...